Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Syndrome
Clinical trial NCT05114941 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05114941
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-01
- Primary completion
- 2026-12-01
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.